3099599-58-0
Chemical Structure
Anticancer agent 352
- CAS No.: 3099599-58-0
- Formula:C51H54N10O3S
- Molecular Weight:887.10
InChIKey: DLZAOKOPNLGWPO-YXQXOBOSSA-N
SMILES: CC1=C(C)SC2=C1C(C3=CC=C(N4CCC(O)(CC4)CN5CCN(C6=CC=C([C@H]7C8=CC=C(O)C=C8CC[C@H]7C9=CC=CC=C9)N=N6)CC5)C=C3)=N[C@H](CC%10=NC=CO%10)C%11=NN=C(C)N2%11
Biological Activity: Anticancer agent 352 is a heterobifunctional anticancer compound. Anticancer agent 352 exhibits only weak antiproliferative activity against both ERα-overexpressing and non-overexpressing T-Rex 293 cells induced by Doxorubicin (HY-15142A). Anticancer agent 352 can be used in breast cancer-related research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Anticancer agent 352 | Anticancer agent 352 is a heterobifunctional anticancer compound. Anticancer agent 352 exhibits only weak antiproliferative activity against both ERα-overexpressing and non-overexpressing T-Rex 293 cells induced by Doxorubicin (HY-15142A). Anticancer agent 352 can be used in breast cancer-related research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
